TAO Synergies TAOX
NASDAQ TAOX
$3.56 +0.18 (+5.31%)
As of: Oct 21, 2026 · 12:55 PM EDT

TAO Synergies (TAOX) Revenue (2025 - 2026)

Updated

TAO Synergies' Revenue was $88,626 in Q2 2026, compared with $3,962 a year earlier and down 77.2% from the prior quarter.

Analysis

TAO Synergies (TAOX) Revenue (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, TAO Synergies' Revenue was $772,499 through Jun 30, 2026; for FY2025, it was $299,061.

  • Quarterly Revenue has moved between $3,962 (Q2 2025) and $388,774 (Q1 2026) over five years.
  • Per Business Quant data, TAOX's Revenue in the three quarters before Q2 2026 was $388,774 (Q1 2026), $91,728 (Q4 2025) and $203,371 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn 16.99 Bn
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 15.03 Bn
10 TAO Synergies 26.59 Mn 644,101.16 - 88,626.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 88,626.00
Mar 31, 2026 388,774.00
Dec 31, 2025 91,728.00
Sep 30, 2025 203,371.00
Jun 30, 2025 3,962.00
API Access

TAO Synergies Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=TAOX&period=max&api_key=YOUR_API_KEY